Kanes Stephen
Chief Medical Officer at Sage Therapeutics, Inc.
- Sold, on record
- $14.5M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Feb 8, 2019
- Form 144 notices
- 0
- Proposed sales
- Quarters with a sale
- 0 of the last 8
- No sale in two years
- Companies
- 1
- Filed as an executive or holder
Companies
- Sage Therapeutics, Inc.Chief Medical Officer
Sales by reason
0
Routine
6
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Feb 8, 2019Unusual
Sold 96.1% of their holdings
$3.4M22,948 shares at $150.00
- Jan 10, 2018Unusual
Sold 93.7% of their holdings
$7.8M44,000 shares at $177.18
- Apr 19, 2016Unusual
Sold 44.7% of their holdings
$798k21,000 shares at $38.00
- Sep 28, 2015Plan not stated
Sold 11.3% of their holdings
$279k6,000 shares at $46.42
- Aug 31, 2015Unusual
Sold 27.3% of their holdings
$637k12,000 shares at $53.12
- Jul 27, 2015Plan not stated
Sold 10.1% of their holdings
$347k4,936 shares at $70.24
- Jun 24, 2015Plan not stated
Sold 11.3% of their holdings
$444k6,000 shares at $74.06
- Mar 25, 2015Plan not stated
Sold 10.3% of their holdings
$278k5,400 shares at $51.49
- Feb 25, 2015Plan not stated
Sold 10.3% of their holdings
$252k6,000 shares at $42.05
- Jan 26, 2015Plan not stated
Sold 9.3% of their holdings
$224k6,000 shares at $37.29
10 of 10
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Jun 24, 2026 | CNTA | Chief Medical Officer | Returned to the companyShare Option (right to buy) | 500,000 | 0 | SEC | ||
| Jun 24, 2026 | Jun 24, 2026 | CNTA | Chief Medical Officer | Returned to the company | 120,000 | 0 | SEC | ||
| Feb 2, 2026 | Feb 3, 2026 | CNTA | Chief Medical Officer | Awarded | 120,000 | 120,000 | SEC | ||
| Feb 3, 2025 | Feb 4, 2025 | CNTA | Chief Medical Officer | AwardedShare Option (right to buy) | 500,000 | 500,000 | SEC | ||
| Oct 19, 2021 | Oct 21, 2021 | Sage Therapeutics, Inc. | Chief Medical Officer | Withheld for tax | 1,120 | $40.29 | $45k | 13,471 | SEC |
| Oct 19, 2021 | Oct 21, 2021 | Sage Therapeutics, Inc. | Chief Medical Officer | Awarded | 3,800 | 14,591 | SEC | ||
| Jun 15, 2021 | Jun 17, 2021 | Sage Therapeutics, Inc. | Chief Medical Officer | Withheld for tax | 1,001 | $58.80 | $59k | 10,791 | SEC |
| Jun 15, 2021 | Jun 17, 2021 | Sage Therapeutics, Inc. | Chief Medical Officer | Awarded | 3,500 | 11,792 | SEC | ||
| Feb 10, 2021 | Feb 12, 2021 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 19,000 | 19,000 | SEC | ||
| Apr 28, 2020 | Apr 30, 2020 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 9,450 | 9,450 | SEC | ||
| Feb 12, 2020 | Feb 14, 2020 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 17,500 | 17,500 | SEC | ||
| Sep 4, 2019 | Sep 5, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 6,000 | 86,100 | SEC | ||
| Sep 4, 2019 | Sep 5, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 6,000 | $0.45 | $3k | 8,292 | SEC |
| Jul 25, 2019 | Jul 29, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Withheld for tax | 549 | $161.38 | $89k | 2,292 | SEC |
| Jul 25, 2019 | Jul 29, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Awarded | 1,900 | 2,841 | SEC | ||
| Jun 21, 2019 | Jun 25, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 6,600 | 13,200 | SEC | ||
| Feb 13, 2019 | Feb 15, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 19,000 | 19,000 | SEC | ||
| Feb 8, 2019 | Feb 8, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 22,948 | $150.00 | $3.4M | 941 | SEC |
| Dec 7, 2018 | Dec 11, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 6,600 | 6,600 | SEC | ||
| Apr 2, 2018 | Apr 4, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 27,000 | 27,000 | SEC | ||
| Jan 12, 2018 | Jan 12, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 20,000 | 111,432 | SEC | ||
| Jan 12, 2018 | Jan 12, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 20,000 | $0.45 | $9k | 22,948 | SEC |
| Jan 10, 2018 | Jan 12, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 44,000 | $177.18 | $7.8M | 2,948 | SEC |
| Feb 6, 2017 | Feb 8, 2017 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 40,000 | 40,000 | SEC | ||
| Dec 8, 2016 | Dec 16, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 14,400 | 68,000 | SEC | ||
| Apr 20, 2016 | Apr 21, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 21,000 | 112,100 | SEC | ||
| Apr 20, 2016 | Apr 21, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 21,000 | $0.45 | $9k | 46,948 | SEC |
| Apr 19, 2016 | Apr 21, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 21,000 | $38.00 | $798k | 25,948 | SEC |
| Feb 8, 2016 | Feb 10, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 20,000 | 20,000 | SEC | ||
| Sep 28, 2015 | Sep 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 6,000 | $46.42 | $279k | 46,948 | SEC |
| Sep 28, 2015 | Sep 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 21,000 | 133,100 | SEC | ||
| Sep 28, 2015 | Sep 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 21,000 | $0.45 | $9k | 52,948 | SEC |
| Aug 31, 2015 | Sep 1, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 12,000 | $53.12 | $637k | 31,948 | SEC |
| Jul 27, 2015 | Jul 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 4,936 | $70.24 | $347k | 43,948 | SEC |
| Jul 27, 2015 | Jul 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 1,936 | 154,100 | SEC | ||
| Jul 27, 2015 | Jul 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 1,936 | $0.45 | $871 | 48,884 | SEC |
| Jun 24, 2015 | Jun 25, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 6,000 | $74.06 | $444k | 46,948 | SEC |
| Jun 24, 2015 | Jun 25, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (Right to Buy) | 6,000 | 40,300 | SEC | ||
| Jun 24, 2015 | Jun 25, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 6,000 | $0.45 | $3k | 52,948 | SEC |
| Mar 25, 2015 | Mar 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 5,400 | $51.49 | $278k | 46,948 | SEC |
| Feb 25, 2015 | Feb 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 6,000 | $42.05 | $252k | 52,348 | SEC |
| Jan 26, 2015 | Jan 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Sold | 6,000 | $37.29 | $224k | 58,348 | SEC |
| Jan 23, 2015 | Jan 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | AwardedStock Option (Right to Buy) | 68,000 | 68,000 | SEC | ||
| Aug 28, 2014 | Jan 26, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised or settledStock Option (right to buy) | 61,348 | 6,774 | SEC | ||
| Aug 28, 2014 | Jan 26, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Exercised options | 61,348 | $0.47 | $29k | 64,348 | SEC |
| Jul 23, 2014 | Jul 23, 2014 | Sage Therapeutics, Inc. | Chief Medical Officer | Bought | 3,000 | $18.00 | $54k | 3,000 | SEC |
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2019 | Feb 8, 2019 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 22,948 | $3.4M | 96.1% | Unusual | SEC |
| Jan 10, 2018 | Jan 12, 2018 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 44,000 | $7.8M | 93.7% | Unusual | SEC |
| Apr 19, 2016 | Apr 21, 2016 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 21,000 | $798k | 44.7% | Unusual | SEC |
| Sep 28, 2015 | Sep 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 6,000 | $279k | 11.3% | Plan not stated | SEC |
| Aug 31, 2015 | Sep 1, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 12,000 | $637k | 27.3% | Unusual | SEC |
| Jul 27, 2015 | Jul 29, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 4,936 | $347k | 10.1% | Plan not stated | SEC |
| Jun 24, 2015 | Jun 25, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 6,000 | $444k | 11.3% | Plan not stated | SEC |
| Mar 25, 2015 | Mar 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 5,400 | $278k | 10.3% | Plan not stated | SEC |
| Feb 25, 2015 | Feb 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 6,000 | $252k | 10.3% | Plan not stated | SEC |
| Jan 26, 2015 | Jan 27, 2015 | Sage Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 6,000 | $224k | 9.3% | Plan not stated | SEC |